CS
RXDX

Comerica Securities’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Comerica Securities’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-6
Closed -$660 – 1494
2022
Q4 		$660 Buy
+6
New +$660 ﹤0.01% 1393